Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) EVP Andrew Turitz sold 1,617 shares of the company's stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total value of $11,577.72. Following the completion of the sale, the executive vice president now owns 41,546 shares of the company's stock, valued at $297,469.36. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Teladoc Health Price Performance
TDOC stock opened at $7.44 on Thursday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.66 and a quick ratio of 1.62. The firm has a market capitalization of $1.26 billion, a P/E ratio of -5.28 and a beta of 0.90. The business's 50-day moving average is $8.34 and its two-hundred day moving average is $11.55. Teladoc Health, Inc. has a 1 year low of $6.76 and a 1 year high of $23.18.
Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.36) by $0.08. Teladoc Health had a negative return on equity of 10.25% and a negative net margin of 38.54%. The company had revenue of $642.44 million for the quarter, compared to analyst estimates of $649.34 million. Analysts anticipate that Teladoc Health, Inc. will post -0.71 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Teladoc Health
Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳
From Mode Mobile | Ad
45M Users | 32,481% Growth RateGet in on the biggest disruption to smartphones in over a decade. Reg A investment now open.
Claim Exclusive 100% Bonus: $0.25/Share
Several institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in Teladoc Health by 11.8% during the fourth quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider's stock worth $377,451,000 after purchasing an additional 1,855,480 shares during the last quarter. Point72 Asset Management L.P. lifted its stake in Teladoc Health by 221.9% during the second quarter. Point72 Asset Management L.P. now owns 5,303,123 shares of the health services provider's stock worth $51,865,000 after purchasing an additional 3,655,436 shares during the last quarter. Rubric Capital Management LP purchased a new stake in Teladoc Health during the second quarter worth approximately $45,267,000. Clearline Capital LP lifted its stake in Teladoc Health by 395.6% during the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider's stock worth $42,682,000 after purchasing an additional 3,483,665 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in Teladoc Health by 25.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider's stock worth $82,636,000 after purchasing an additional 767,999 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company's stock.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on TDOC. Evercore ISI dropped their target price on Teladoc Health from $14.00 to $10.00 and set an "in-line" rating for the company in a report on Tuesday, July 9th. Deutsche Bank Aktiengesellschaft dropped their target price on Teladoc Health from $15.00 to $10.00 and set a "hold" rating for the company in a report on Friday, August 2nd. Stifel Nicolaus dropped their target price on Teladoc Health from $16.00 to $9.00 and set a "hold" rating for the company in a report on Thursday, August 1st. TD Cowen lowered their price target on Teladoc Health from $15.00 to $9.00 and set a "hold" rating for the company in a report on Thursday, August 1st. Finally, Canaccord Genuity Group lowered their price target on Teladoc Health from $25.00 to $17.00 and set a "buy" rating for the company in a report on Thursday, August 1st. Fourteen equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $12.44.
View Our Latest Stock Analysis on Teladoc Health
Teladoc Health Company Profile
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Further Reading
- Five stocks we like better than Teladoc Health
- 3 Warren Buffett Stocks to Buy Now
- Why the Recent Drop in Palantir Could Be a Perfect Buying Moment
- There Are Different Types of Stock To Invest In
- Agilent Technologies Thrives From the Forever Chemicals Crackdown
- Manufacturing Stocks Investing
- How Starbucks and Airbnb Fit Buffett’s Winning Stock Strategy
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [emailprotected].
Insider Buying or Selling at Teladoc Health?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Teladoc Health and related companies.
More From MarketBeat
